Business Services Industry

INDIA: SANDOZ SETS UP NEW PLANT IN INDIA.

IPR Strategic Business Information Database, May, 2004

Sandoz, the generics division of drug maker Novartis, has invested US$13 million in a third production facility in India. The investment is part of the company's global expansion of production facilities. The new unit will primarily focus on manufacturing for highly regulated markets like the US and European Union.

The facility has a capacity to produce 1 billion tablets and capsules annually and is designed to conform to USFDA standards. - (EMEconomy.com)

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here